PART I Introduction Bausch Health Companies Inc. (we, us, our, the Company or Bausch Health) is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and aesthetic medical devices and, through our approximately 88% ownership of Bausch +...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-19 | 2025-12-31 | 0000885590-26-000023 | EDGAR | 134K words |
| 2025-02-20 | 2024-12-31 | 0000885590-25-000007 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0000885590-24-000011 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000885590-23-000009 | EDGAR | — |
| 2022-02-23 | 2021-12-31 | 0000885590-22-000010 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0000885590-21-000011 | EDGAR | — |
| 2020-02-19 | 2019-12-31 | 0000885590-20-000006 | EDGAR | — |
| 2019-02-20 | 2018-12-31 | 0000885590-19-000006 | EDGAR | — |
| 2018-02-28 | 2017-12-31 | 0000885590-18-000017 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0000885590-17-000015 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-30 | 2025-09-30 | 0000885590-25-000051 | EDGAR | 65K words |
| 2025-07-31 | 2025-06-30 | 0000885590-25-000032 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000885590-25-000020 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0000885590-24-000036 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000885590-24-000029 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000885590-24-000019 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000885590-23-000035 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000885590-23-000028 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000885590-23-000018 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000885590-22-000061 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000885590-22-000039 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0000885590-22-000025 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001193125-26-085755 | EDGAR | 1K words |
| 2026-02-18 | 0000885590-26-000020 | EDGAR | — |
| 2026-01-23 | 0000885590-26-000008 | EDGAR | — |
| 2026-01-13 | 0000885590-26-000005 | EDGAR | — |
| 2026-01-02 | 0000950103-26-000052 | EDGAR | — |
| 2025-12-29 | 0000885590-25-000059 | EDGAR | — |
| 2025-12-23 | 0000885590-25-000057 | EDGAR | — |
| 2025-12-12 | 0000950103-25-016089 | EDGAR | — |
| 2025-12-09 | 0000885590-25-000054 | EDGAR | — |
| 2025-11-24 | 0001193125-25-291998 | EDGAR | — |
256 total filings indexed. 224 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000885590 |
| Ticker | BHC |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NJ |
| Website | https://www.bauschhealth.com |
| Listed | 1994-03-31 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report